Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study.

Ming-Wei LaiChao-Wei HsuChih-Lang LinRong-Nan ChienWey-Ran LinChi-Sheng ChangKung-Hao LiangChau-Ting Yeh

Published in: Hepatology international (2018)

In low-level HBsAg CHB patients, serial HBsAg-based vaccinations were safe, resulting in significant HBsAg decline. HLA gene expression and genotypes played a role in vaccine responsiveness (ClinicalTrials.gov Identifier: NCT01817725).

Keyphrases

hepatitis b virus
gene expression
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
dna methylation
prognostic factors
peritoneal dialysis